Pregnancy and Childbirth
Conditions
Interventions
Vaginal Misoprostol
Sponsors
Matega Habiragi
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Nulliparous and multiparous, followed prenatal counselling in one of the selected structures, term pregnancy, one fetus, fetal heart sounds within the norms (110-160 beats per minute) and cephalic presentation
Exclusion criteria
Exclusion criteria: Women who have already given birth more than 5 times, pregnant women with twin or multiple pregnancies, gravid hypertension, preeclampsia, gestational diabetes or chronic unbalanced diabetes, uterine height greater than 36 cm presentation other than cephalic, fetal heart rhythm disorders before induction, placenta previa, pregnancy on fibromyomatous uterus, petal-pelvic disproportion, pelvic anomalies, fetal death.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes were the effectiveness of Misoprostol in inducing uterine contractions by both routes | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes were the safety of the route of administration as well as its assessment elements which were time to first uterine contractions compared to the first dose, duration of labor and rate of vaginal delivery, the maternal prognosis: hyperkinesia, hypertonia, prerupture or uterine rupture, cesarean section rate, postpartum hemorrhage, fever, chills, nausea, vomiting, diarrhea, and perinatal prognosis: fetal distress, meconium staining of amniotic fluid, Apgar score at the first, fifth and tenth minute, need and duration of resuscitation, perinatal mortality. | — |
Countries
Zaire
Contacts
Public ContactMaindo Alongo
Gynecologist and Obstetrician Kisangani University
Outcome results
None listed